INTELLECTUAL PROPERTY AND PATENTS. 27.1 Intellectual property consists of inventions, publications, computer software, courseware, works of art and music, data bases, lecture notes, laboratory manuals, articles, books, as well as all other creations that can be protected under patent, copyright, trademark or similar laws.
INTELLECTUAL PROPERTY AND PATENTS. 2.5.1 Both the supervisor and student are aware that intellectual property, including data generated during postgraduate research and study, belongs to Stellenbosch University, according to the SU IP policy. Copies of all data (raw and analysed) must be submitted to the supervisor on completion of the study (General Policies and Rules: Calendar Part 1) (In case of any IP related queries please contact Innovus).
INTELLECTUAL PROPERTY AND PATENTS. (a) Intellectual Property (“IP”) means all copyright and all rights in relation to inventions (including patent rights), registered and unregistered trademarks (including service marks), registered and unregistered designs, circuit layouts, and any other rights resulting from intellectual activity in the industrial, scientific, literary and artistic fields recognised in domestic law anywhere in the world.
INTELLECTUAL PROPERTY AND PATENTS. (a) Safran will retain and own all right, title and interest in and to any intellectual property (x) that Safran owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to Safran, Buyer irrevocably agrees that Safran shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s procesadores) sin la autorización previa y expresa por escrito de la otra parte. Ninguna de las partes copiará, almacenará o transferirá a otros países los Datos Personales sin la autorización previa y expresa por escrito de la otra parte.
INTELLECTUAL PROPERTY AND PATENTS. ImmunoClin, Ltd’s intellectual property and patents are including, but are not limited to, the following: All intellectual property created by ImmunoClin, Ltd and All patents filed, in-process, or contemplated by ImmunoClin, Ltd. Patent Title Applicant (s) / country Filing date HIGH THROUGHPUT DETERMINATION OF ANTIGEN EXPRESSION IMMUNOCLIN LABORATORIES LIMITED (United Kingdom) 27.11.2000 ASSAY METHOD FOR EVALUATING CELL RESPONSES TO INFECTION IMMUNOCLIN LABORATORIES LIMITED (United Kingdom) 01.11.2000 TREATMENT WITH CYTOKINES FOR ALZHEIMER'S DISEASE IMMUNOCLIN, LTD. (United Kingdom) 31.05.2002 MARKER GENE IMMUNOCLIN, LTD. (United Kingdom) OSAKA INDUSTRIAL PROMOTION ORGANISATION (JAPAN) 16.10.2002 BIOMARKERS OF RESISTANCE TO INFECTIONS IN HUMANS AND BIOLOGICAL APPLICATION THEREOF (IL-22) INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD) (France) IMMUNOCLIN, LTD. (United Kingdom) 5.11.2003
INTELLECTUAL PROPERTY AND PATENTS. 9.1 Inventorship shall be determined according to United States Patent law.
INTELLECTUAL PROPERTY AND PATENTS. 2.1. The Employee undertakes to immediately bring to Teva’s attention or the attention of whoever is designated by Teva, all Confidential Information or other information, created, developed or which came to Employee’s attention and which relates to Teva’s field of operations, including any improvement, invention, innovation, process, creation, discovery, formula, technique, conclusions, knowledge, findings, research results, examination or experiment, developments, designs, ideas, etc., whether or not patentable or eligible to be protected as another proprietary right, whether or not forming the subject-matter of an application for registration of the right, whether or not it constitutes a service invention in accordance with the law, which were made, conceived, produced or implemented, developed or formed, in whole or in part, by the Employee alone or jointly with others, in Israel or abroad, during the Term of Employment at Teva or in connection with the Employee’s work at Teva (hereinafter, jointly and severally: “Information Created by the Employee”). For the avoidance of any doubt, it is hereby clarified that Information Created by the Employee will include, inter alia, information created, formed or developed after the commencement of the Term of Employment (even if conceived or developed prior to the execution of this Letter of Undertaking) and/or after termination thereof, provided that the information relates, directly or indirectly, to the Employee’s work and/or employment with Teva
INTELLECTUAL PROPERTY AND PATENTS. 8.1 Patent ownership. Syngenta shall own the entire right, title, and interest in and to all Patent Rights and shall have the exclusive right to apply for, seek issuance of, and maintain or abandon any or all of Syngenta's Patent Rights.
INTELLECTUAL PROPERTY AND PATENTS. The Ekosolve process has a number of inventions and techniques to achieve the extremely high recovery of lithium from saltwater brines. The Board has decided at this stage to keep the intellectual property a trade secret between the inventors and the University. While some of the components are readily available, it took more than five years research and collaboration to refine the final Ekosolve™ process. There are many trade secret chemical processes that have been able to protect their processes, the most famous being Coca-Cola™ and Kentucky Fried Chicken™. The Board is leaving open the possibility of patenting in USA, Australia and Europe any developments of “Prior Art” Inventions that may result from the development of the Ekosolve™ Process over time. However, as at the date of this Information Memorandum, the Company has no patents, patent applications or other formal means of intellectual property protection.
INTELLECTUAL PROPERTY AND PATENTS. The Buyer shall hold REFRACTRON harmless against any expenses, damages, costs, or losses resulting from any suit or proceeding brought for infringement of patents, copyrights, trademarks or trade secrets or for unfair competition arising from compliance with Buyer’s designs or specifications or instructions.
